Neogenomics Inc
NEO· Nasdaq
NEONeogenomics Inc
Filed Mar 3, 2015 · 10-K · 62 days after period end · 0001193125-15-075318
| Metric | Q4 2014 | Q4 2013 | Q4 2012 | Q4 2011 |
|---|---|---|---|---|
| Net Income | $1.05M | $857.00K | -$114.00K | $152.00K |
| EPS Diluted | $0.02 | $0.02 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Neogenomics Inc · CIK 1077183 · Engraved from SEC EDGAR
ended Dec 31, 2014 · filed Mar 3, 2015 · 62 d after period end
